1. Home
  2. VANI vs STHO Comparison

VANI vs STHO Comparison

Compare VANI & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.43

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

STHO

Star Holdings Shares of Beneficial Interest

HOLD

Current Price

$9.78

Market Cap

118.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VANI
STHO
Founded
1998
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
118.3M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
VANI
STHO
Price
$1.43
$9.78
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
166.8K
15.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.73
EPS
N/A
2.58
Revenue
$4,000,000.00
$110,143,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.83
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$7.08
52 Week High
$1.92
$9.94

Technical Indicators

Market Signals
Indicator
VANI
STHO
Relative Strength Index (RSI) 52.89 62.13
Support Level $1.26 $8.71
Resistance Level $1.55 N/A
Average True Range (ATR) 0.08 0.27
MACD -0.00 0.01
Stochastic Oscillator 43.23 93.05

Price Performance

Historical Comparison
VANI
STHO

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.

Share on Social Networks: